Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists

Citation
We. Minke et al., Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists, BIOCHEM, 38(18), 1999, pp. 5684-5692
Citations number
44
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMISTRY
ISSN journal
00062960 → ACNP
Volume
38
Issue
18
Year of publication
1999
Pages
5684 - 5692
Database
ISI
SICI code
0006-2960(19990504)38:18<5684:SEOTGG>2.0.ZU;2-T
Abstract
Ganglioside GM1 is the natural receptor for cholera toxin (CT) and heat-lab ile enterotoxin (LT), which are the causative agents of cholera and travele r's diarrhea, respectively. This observation suggests that small molecules interfering with this recognition process may prevent entry of the toxins i nto intestinal cells, thereby averting their devastating effects. Here, the terminal sugar of ganglioside GM1, galactose, was chosen as a lead in desi gning such receptor antagonists. Guided by the experimentally determined bi nding mode of galactose, we selected a "substructure" for searching the Ava ilable Chemicals Database, which led to the purchase of 35 galactose deriva tives. Initial screening of these compounds in an LT ELISA revealed that 22 of them have a higher affinity for LT than galactose itself. A structurall y diverse subset of these galactose derivatives was selected for determinat ion of IC50 values in the LT ELISA and IC50 values in a CT assay, as well a s for the determination of K-d's using the intrinsic fluorescence of LT. Th e best receptor antagonist found in this study was m-nitrophenyl alpha-gala ctoside with an IC50 of 0.6 (2) mM in the LT ELISA and 0.72 (4) mM in the C T assay, 100-fold lower than both IC50 values of galactose. Careful analysi s of our binding data and comparison with crystal structures led to the der ivation of correlations between the structure and affinity of the galactose derivatives. These characteristics will be used in the design of a second round of LT and CT receptor antagonists.